# eXoZymes, Inc. (EXOZ)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/EXOZ/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 0 | $ -5.25M | $ -3.22M | $ 1.09M | $ 3.65M |
| 2025 | $ 0 | $ -9.38M | $ -6.83M | $ 1.24M | $ 3.40M |
| 2024 | $ 0 | $ -6.16M | $ -9.36M | $ 1.39M | $ 10.42M |
| 2023 | $ 0 | $ -2.20M | $ -1.59M | $ 1.61M | $ -384.3K |
| 2022 | $ 0 | $ -437.8K | $ -173.0K | $ 608.8K | $ 1.37M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.30 |
| Liabilities / Eq | 1.18 |
| Current Ratio | 3.81 |

## Other views

- [Metrics](https://sponda.capital/en/EXOZ.md)
- [Charts](https://sponda.capital/en/EXOZ/charts.md)
- [Compare](https://sponda.capital/en/EXOZ/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-29.